tiprankstipranks
Artelo Biosciences Inc (ARTL)
NASDAQ:ARTL
US Market

Artelo Biosciences (ARTL) Financial Statements

Compare
471 Followers

Artelo Biosciences Financial Overview

Artelo Biosciences's market cap is currently $3.87M. The company's EPS TTM is $-2.844; its P/E ratio is ―; Artelo Biosciences is scheduled to report earnings on March 26, 2025, and the estimated EPS forecast is $-0.44. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Sep 21Sep 20Sep 19
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ 0.00
Operating Income$ -10.29M$ -7.44M$ -4.69M$ -3.21M
EBITDA$ -10.29M$ -7.44M$ -4.71M$ -4.22M
Net Income$ -9.87M$ -7.44M$ -4.65M$ -2.17M
Balance Sheet
Cash & Short-Term Investments$ 17.53M$ 10.06M$ 2.14M$ 4.42M
Total Assets$ 20.42M$ 12.63M$ 4.38M$ 6.48M
Total Debt$ 63.00K$ 95.00K$ 0.00$ 0.00
Net Debt$ -6.83M$ -6.53M$ -2.14M$ -4.42M
Total Liabilities$ 1.02M$ 593.00K$ 502.18K$ 1.02M
Stockholders' Equity$ 19.40M$ 12.04M$ 3.87M$ 5.46M
Cash Flow
Free Cash Flow$ -8.01M$ -6.14M$ -4.35M$ -4.29M
Operating Cash Flow$ -8.01M$ -6.14M$ -4.35M$ -2.79M
Investing Cash Flow$ 2.96M$ -3.44M$ 0.00$ -1.50M
Financing Cash Flow$ 0.00$ 14.11M$ 1.98M$ 8.38M
Currency in USD

Artelo Biosciences Earnings and Revenue History

Artelo Biosciences Debt to Assets

Artelo Biosciences Cash Flow

Artelo Biosciences Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis